# FDA Inspection 1091059 - Avadel Legacy Pharmaceuticals LLC - April 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/b8dfa10b-db4c-47a2-9ae1-dc30ee015391
Source feed: FDA_Inspections

> FDA Inspection 1091059 for Avadel Legacy Pharmaceuticals LLC on April 24, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091059
- Company Name: Avadel Legacy Pharmaceuticals LLC
- Inspection Date: 2019-04-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1068774 - 2018-10-11](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/e71a25aa-5ff3-46b9-a048-5727c10e27bb)
- [FDA Inspection 1027967 - 2017-10-06](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/191b05f6-5158-4424-8e07-eb0fdabba68c)
- [FDA Inspection 1027967 - 2017-10-06](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/ae12886a-68ec-44c6-8766-3ac94c6b0e1c)
- [FDA Inspection 1027967 - 2017-10-06](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/ef4e5ca0-ac2b-488b-8b2b-fc90c7521427)
- [FDA Inspection 946968 - 2015-09-23](https://www.keypedia.com/records/fda_inspections/avadel-legacy-pharmaceuticals-llc/4d1c3786-cba8-4f1a-9d8e-be287153e030)

Company: https://www.keypedia.com/companies/avadel-legacy-pharmaceuticals-llc/b4511df8-4278-4924-9a28-a3600d1fdc71

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c